Abstract | OBJECTIVE: METHODS: DNA sequence analysis of the CASR gene was undertaken in autosomal dominant hypoparathyroidism and familial hypocalciuric hypercalcemia Japanese patients, and the functional consequences for the Gi-MAPK pathway and cell surface expression of CASR were determined. Furthermore, we studied the effect of NPS R-568 and NPS 2143 on the signal transduction activity and cell surface expression of each mutant CASR. RESULTS: We identified 3 activating mutations (S122C, P569H, and I839T) and 2 inactivating mutations (A110T and R172G) in patients. The activating and inactivating mutations caused leftward and rightward shifts, respectively, in the dose-response curves of the signaling pathway. NPS R-568 rescued the signal transduction capacity of 2 inactivating mutants without increasing cell surface expression levels. NPS 2143 suppressed the enhanced activity of the activating mutants without altering cell surface expression levels, although A843E, which is a constitutively active mutant, was suppressed to a lesser degree. CONCLUSIONS: We have identified 4 novel mutations of CASR. Moreover, our results indicate that allosteric modulators can restore the activity of the loss- and gain-of-function mutant CASRs, identified in this study.
|
Authors | Akie Nakamura, Tomoyuki Hotsubo, Keiji Kobayashi, Hiroshi Mochizuki, Katsura Ishizu, Toshihiro Tajima |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 98
Issue 10
Pg. E1692-701
(Oct 2013)
ISSN: 1945-7197 [Electronic] United States |
PMID | 23966241
(Publication Type: Journal Article)
|
Chemical References |
- Receptors, Calcium-Sensing
|
Topics |
- Child
- Humans
- Hypercalcemia
(congenital, genetics)
- Hypoparathyroidism
(genetics)
- Infant
- Infant, Newborn
- Mutation
- Receptors, Calcium-Sensing
(genetics)
|